Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 11Recruiting 2Not yet recruiting 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 1

Conditions

Obesity 13Sexual Dysfunction, Physiological 6Breast Neoplasms 5Overweight 4Neoplasms 4Mucositis 3Endometrial Neoplasms 3Cancer-related Fatigue 3Sexual Dysfunctions, Psychological 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Motor Activity 2Leukemia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Constipation 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Pediatric Obesity 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1

Interventions

exemestane 1Leuprolide 1Letrozole 1Goserelin 1Gonadotropin-Releasing Hormone 1Bupropion 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Sexual Dysfunctions, Psychological × Other × Clear all
NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT06906575 2025-04-02

WTL

Central South University

Phase NA Not yet recruiting
100 enrolled
Other

Neoplasms, Sexual Dysfunctions, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡